Grand Hôpital de Charleroi - Notre Dame

Charleroi 6000

0 studies enrolling now · 4 studies all time

What they study most

Acute Myeloid Leukemia, Leukemia, Myelomonocytic, Chronic, Locally Advanced or Metastatic Unresectable Urothelial Cancer, Myelodysplastic Syndromes, Refractory Hodgkin Lymphoma, Relapsed Hodgkin Lymphoma

Studies at this site

• Study of Sacituzumab Govitecan Versus Physician's Choice of Treatment in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread — Completed
• Study of Magrolimab in Combination With Azacitidine Versus Physician's Choice of Venetoclax in Combination With Azacitidine or Intensive Chemotherapy in Patients With TP53 Mutant Acute Myeloid Leukemia That Have Not Been Treated — Stopped early
• Guadecitabine (SGI-110) vs Treatment Choice in Adults With MDS or CMML Previously Treated With HMAs — Completed
• Study to Evaluate the Efficacy and Safety of Camidanlumab Tesirine (ADCT-301) in Patients With Relapsed or Refractory Hodgkin Lymphoma — Completed